China Petroleum & Chemical (386)
4.29 HKD -0.01 (-0.23%) Volume: 116.32M
China Petroleum & Chemical’s stock price stands at 4.29 HKD, witnessing a slight dip of -0.23% in this trading session with a trading volume of 116.32M. Despite the minor drop, the company’s stock has shown resilience with a positive YTD change of +4.89%, highlighting its promising performance in the market.
Latest developments on China Petroleum & Chemical
China Petroleum & Chemical, also known as Sinopec, recently completed China’s first factory-based seawater hydrogen production project at its Qingdao Refinery. This milestone comes as Sinopec forecasts that China’s petroleum consumption is set to peak by 2027. With 2024 marked as a turning point for the country’s refined oil market, investors are closely monitoring these developments, which could potentially impact Sinopec’s stock price movements in the near future.
A look at China Petroleum & Chemical Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 5 | |
Growth | 3 | |
Resilience | 3 | |
Momentum | 3 | |
OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Petroleum & Chemical Corporation, also known as Sinopec, has received high scores in both value and dividend categories, indicating a positive long-term outlook for the company. With strong financials and a commitment to rewarding shareholders through dividends, investors may find China Petroleum & Chemical to be a solid investment choice.
While the company scores lower in growth, resilience, and momentum categories, it is important to consider the overall balanced performance of China Petroleum & Chemical. Despite facing challenges in terms of growth and resilience, the company’s strong value and dividend scores suggest stability and potential for long-term growth in the petroleum and petrochemical industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars